These disorders are caused by mutations in MYH9, which encodes the non-muscle myosin heavy chain IIA protein.[1] The clinical manifestations of MYH9-RDs vary widely, ranging from mild cases of isolated thrombocytopenia to more severe forms associated with progressive nephropathy, hearing loss, and cataracts.[2]. The gene discussed is MYH9; the disease is cataract.